Company Search:
Advanced Search
Sponsored Links
Nantkwest Inc Company Snapshot
Nantkwest Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nantkwest Inc with three other companies in this sector in UNITED STATES : Intra-Cellular Therapies Inc (2019 sales of $60,613.00 of which 100% was Pharmaceutical), Iterum Therapeutics PLC ($37,000.00 of which 100% was Drug Resistant Bacterial Infection), and Forte Biosciences Inc ($36,000.00 of which 100% was therapeutic genes).

Sales Analysis. During the year ended December of 2019, sales at Nantkwest Inc were $43,000.00 . This is a decrease of 8.5% versus 2018, when the company's sales were $47,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Nantkwest Inc
  Stock Performance Chart for Nantkwest Inc
  Stock Data: Recent Stock Performance:
  Current Price (7/10/2020): 13.80
(Figures in U.S. Dollars)
1 Week 15.1%   13 Weeks 100.6%  
4 Weeks 361.5%   52 Weeks 1,143.2%  
Nantkwest Inc Key Data:
  Ticker: NK Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 43,000
(Year Ending Jan 2020).
Employees: 148
  Currency: U.S. Dollars Market Cap: 1,359,278,362
  Fiscal Yr Ends: December Shares Outstanding: 98,498,432
  Share Type: Common Closely Held Shares: 70,644,466
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.